Sign In
Buy PEPG
$1.42
-0.0300 (-2.07%)
At Close: Jun 03, 2026
SAN DIEGO, March 31, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of PepGen Inc. (NASDAQ: PEPG). The investigation focuses on whether PepGen o
PepGen Inc. (PEPG) Discusses Topline Results From Lowest Dose MAD Cohort in Phase II FREEDOM2 Study With Favorable Safety, Splicing and vHOT Data Transcript
BOSTON--(BUSINESS WIRE)--PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of se
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
10:00am, Thursday, 26'th Mar 2026
NEW YORK, March 26, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PepGen Inc. ("PepGen" or the "Company") (NASDAQ: PEPG). Such investors are advised to contact
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
10:00am, Thursday, 19'th Mar 2026
NEW YORK, March 19, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PepGen Inc. ("PepGen" or the "Company") (NASDAQ: PEPG). Such investors are advised to contact
PepGen, Inc. (NASDAQ:PEPG) Given Average Recommendation of “Moderate Buy” by Brokerages
02:31am, Thursday, 19'th Mar 2026
Shares of PepGen, Inc. (NASDAQ: PEPG - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the six research firms that are covering the firm, Marketbeat.com reports. O
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
05:28pm, Tuesday, 17'th Mar 2026
NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PepGen Inc. (“PepGen” or the “Company”) (NASDAQ: PEPG). Such investors are advise
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
06:30pm, Thursday, 12'th Mar 2026
NEW YORK, March 12, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PepGen Inc. ("PepGen" or the "Company") (NASDAQ: PEPG). Such investors are advised to contact
PepGen Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
08:00pm, Thursday, 05'th Mar 2026
SAN DIEGO, March 05, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of PepGen Inc. (NASDAQ: PEPG). The investigation focuses on whether PepGen o
US FDA puts partial clinical hold on PepGen's muscle disease drug trial
04:56pm, Wednesday, 04'th Mar 2026
PepGen said on Wednesday that the U.S. Food and Drug Administration has placed a partial clinical hold on its mid‑stage trial of a rare muscle disease drug, sending its shares plunging over 25
PepGen Reports Fourth Quarter and Year-End 2025 Financial Results and Recent Corporate Highlights
04:05pm, Wednesday, 04'th Mar 2026
BOSTON--(BUSINESS WIRE)--PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of se
PepGen Announces Regulatory Updates on FREEDOM2
04:03pm, Wednesday, 04'th Mar 2026
BOSTON--(BUSINESS WIRE)--PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies to treat severe neuromuscular and neurological di
PepGen to Participate in the Leerink Global Healthcare Conference
07:00am, Tuesday, 03'rd Mar 2026
BOSTON--(BUSINESS WIRE)--PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of se
PepGen, Inc. (NASDAQ:PEPG) Receives Consensus Recommendation of “Moderate Buy” from Analysts
03:28am, Sunday, 22'nd Feb 2026
PepGen, Inc. (NASDAQ: PEPG - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the five analysts that are presently covering the firm, MarketBeat.com reports. One researc
PepGen (PEPG) Expected to Announce Earnings on Monday
03:24am, Monday, 16'th Feb 2026
PepGen (NASDAQ: PEPG - Get Free Report) will likely be releasing its Q4 2025 results before the market opens on Monday, February 23rd. Analysts expect PepGen to post earnings of ($0.38) per share for
